VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
DLB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
DLBDolby Laboratories, Inc.
$58.03$5.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDLBFinancials

Dolby Laboratories, Inc. (DLB) Income Statement

23Y historyFree accessUpdated daily

Revenue growth is erratic (Q2 2026 +7.1% vs. Q3 2026 -3.3%), while gross margins remain stable at 86-90%, but operating margins swing widely from 9.7% to 30.3% due to SG&A cost creep and fixed-cost coverage issues.

Income StatementBalance SheetCash FlowRatios

DLB Income Statement

Annual statement

DLB Income Statement

Dolby Laboratories, Inc. (DLB) annual income statement — 23-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03
Sales/Revenue1.35B1.35B1.27B1.3B1.25B1.28B1.16B1.24B1.05B1.08B1.03B970.64M960.18M909.67M926.26M955.5M922.71M719.5M640.23M482.03M391.54M327.97M289.04M217.47M
Revenue Growth %0.55%5.92%-2%3.67%-2.14%10.28%-6.43%17.73%-2.48%5.43%5.68%1.09%5.55%-1.79%-3.06%3.55%28.24%12.38%32.82%23.11%19.38%13.47%32.91%-
Cost of Goods Sold167.78M160.13M140.5M152.57M141.36M130.03M146.5M160.85M127.56M118.31M108.98M94.82M70.18M96.72M92.03M111.17M122.22M84.81M67.78M74.27M76.04M80.22M91.5M73.64M
COGS % of Revenue-11.87%11.03%11.74%11.27%10.15%12.61%12.96%12.1%10.94%10.62%9.77%7.31%10.63%9.94%11.63%13.25%11.79%10.59%15.41%19.42%24.46%31.66%33.86%
Gross Profit1.19B1.19B1.13B1.15B1.11B1.15B1.02B1.08B927.04M963.15M916.76M875.82M890M812.96M834.24M844.33M800.49M634.69M572.45M407.76M315.5M247.75M197.54M143.83M
Gross Margin %87.61%88.13%88.97%88.26%88.73%89.85%87.39%87.04%87.9%89.06%89.38%90.23%92.69%89.37%90.06%88.37%86.75%88.21%89.41%84.59%80.58%75.54%68.34%66.14%
Gross Profit Growth %-4.92%-1.22%3.12%-3.37%13.39%-6.06%16.58%-3.75%5.06%4.67%-1.59%9.48%-2.55%-1.2%5.48%26.12%10.87%40.39%29.24%27.35%25.42%37.34%-
Operating Expenses941.34M924.04M868.51M884.36M895.21M810.47M794.73M787.13M743.98M701.66M683.73M662.27M613.88M561.82M471.05M411.19M354.49M292.2M286.17M222.91M189.54M165.69M129.94M94.85M
OpEx % of Revenue-68.49%68.19%68.04%71.4%63.26%68.41%63.4%70.55%64.88%66.66%68.23%63.93%61.76%50.86%43.03%38.42%40.61%44.7%46.24%48.41%50.52%44.95%43.62%
Selling, General & Admin658.8M647.24M604.85M612.84M634.03M556.83M555.69M549.26M507.19M468.35M464.12M460.95M430.75M393.07M330.91M287.27M249.51M225.49M224.09M178.8M154.16M135.16M106.46M76.59M
SG&A % of Revenue-47.97%47.49%47.15%50.57%43.46%47.83%44.24%48.09%43.31%45.25%47.49%44.86%43.21%35.73%30.07%27.04%31.34%35%37.09%39.37%41.21%36.83%35.22%
Research & Development265.94M261.79M263.66M271.52M261.17M253.64M239.04M237.87M236.79M233.31M219.61M201.32M183.13M168.75M140.14M123.92M104.98M66.71M62.08M44.11M35.38M30.53M23.48M18.26M
R&D % of Revenue-19.4%20.7%20.89%20.83%19.8%20.58%19.16%22.45%21.57%21.41%20.74%19.07%18.55%15.13%12.97%11.38%9.27%9.7%9.15%9.04%9.31%8.12%8.4%
Other Operating Expenses2M15.01M0000000000000000000000
Operating Income245.24M264.96M264.71M262.81M217.23M340.76M220.56M293.63M183.06M261.49M233.03M213.55M276.12M251.14M363.18M433.14M446M342.5M286.28M184.85M125.96M82.06M67.6M47.67M
Operating Margin %18.11%19.64%20.78%20.22%17.33%26.6%18.98%23.65%17.36%24.18%22.72%22%28.76%27.61%39.21%45.33%48.34%47.6%44.72%38.35%32.17%25.02%23.39%21.92%
Operating Income Growth %-0.09%0.72%20.99%-36.25%54.5%-24.89%60.4%-29.99%12.21%9.12%-22.66%9.95%-30.85%-16.15%-2.88%30.22%19.63%54.87%46.76%53.49%21.39%41.82%-
EBITDA348.54M363.56M352.04M358.33M320.84M436.62M311.44M378.76M264.34M345.8M318.18M282.68M329.4M304.38M407.06M477.13M480.94M371.23M311.1M199.66M138.84M93.41M76.12M55.16M
EBITDA Margin %25.74%26.95%27.64%27.57%25.59%34.08%26.81%30.51%25.07%31.98%31.02%29.12%34.31%33.46%43.95%49.94%52.12%51.59%48.59%41.42%35.46%28.48%26.33%25.37%
EBITDA Growth %-10.21%3.27%-1.76%11.69%-26.52%40.19%-17.77%43.28%-23.56%8.68%12.56%-14.18%8.22%-25.22%-14.69%-0.79%29.55%19.33%55.82%43.81%48.63%22.72%37.98%-
D&A (Non-Cash Add-back)103.31M98.6M87.33M95.51M103.61M95.86M90.88M85.12M81.28M84.31M85.15M69.13M53.28M53.24M43.88M43.99M34.94M28.73M24.81M14.8M12.88M11.35M8.52M7.5M
EBIT269.5M279.97M312.48M250.05M215.28M354.51M239.72M282.31M196.37M256.64M235.9M245.78M276.1M250.65M369.19M440.64M437.71M372.35M303.93M212.53M148.41M93.07M70.44M0
Net Interest Income9.42M15.38M34.08M28.09M6.57M3.49M12.72M24.92M18.97M9.58M5.68M4.54M3.34M3.85M6.21M10M6.59M10.33M15.76M23.05M16.96M5.11M-912K-2.15M
Interest Income13.54M15.38M34.08M28.09M6.57M3.49M12.72M24.92M18.97M9.58M5.68M4.54M3.34M3.85M6.41M10M7.3M11.27M17.89M26.16M18.73M6.96M1.44M0
Interest Expense4.12M0000000000000196K0703K935K2.13M3.11M1.77M1.85M2.35M2.15M
Other Income/Expense31.53M38.53M47.77M-12.76M-1.95M13.75M19.15M-11.33M13.31M-4.84M2.88M32.23M-22K-490K5.81M7.5M-8.99M28.92M15.52M24.56M20.68M9.16M491K-219K
Pretax Income276.77M303.49M312.48M250.05M215.28M354.51M239.72M282.31M196.37M256.64M235.9M245.78M276.1M250.65M368.99M440.64M437.01M371.42M301.8M209.42M146.64M91.22M68.09M47.61M
Pretax Margin %20.44%22.49%24.53%19.24%17.17%27.67%20.63%22.74%18.62%23.73%23%25.32%28.75%27.55%39.84%46.12%47.36%51.62%47.14%43.44%37.45%27.81%23.56%21.89%
Income Tax48.77M46.99M48.16M48.41M31.38M36.69M8.1M26.8M154.07M54.22M49.5M62.54M67.38M60.34M103.86M130.06M154.19M127.07M100.77M65.13M55.83M37.33M27.32M16.08M
Effective Tax Rate %17.62%15.48%15.41%19.36%14.58%10.35%3.38%9.49%78.46%21.13%20.98%25.45%24.4%24.08%28.15%29.52%35.28%34.21%33.39%31.1%38.08%40.92%40.12%33.77%
Net Income226.18M255.02M261.82M200.66M184.09M310.23M231.36M255.15M41.75M201.8M185.86M181.39M206.1M189.27M264.3M309.27M283.45M242.99M199.46M142.83M89.55M52.29M39.84M30.97M
Net Margin %16.7%18.9%20.56%15.44%14.68%24.21%19.91%20.55%3.96%18.66%18.12%18.69%21.47%20.81%28.53%32.37%30.72%33.77%31.15%29.63%22.87%15.94%13.78%14.24%
Net Income Growth %-14.41%-2.6%30.48%9%-40.66%34.09%-9.32%511.2%-79.31%8.58%2.46%-11.99%8.89%-28.39%-14.54%9.11%16.65%21.83%39.65%59.5%71.24%31.25%28.65%-
Net Income (Continuing)228M256.49M264.32M201.64M183.9M317.82M231.62M255.5M42.3M202.43M186.4M183.24M208.72M190.3M265.13M310.58M282.83M244.35M201.03M144.28M90.8M53.89M40.77M-
Discontinued Operations000000000000000000000000
Minority Interest9.17M9.39M9.73M17.08M4.84M6.25M5.76M5.68M6.57M7.1M8.48M8.94M21.63M18.92M22.96M21.84M20.94M22M22.1M22.28M19.91M18.26M17.2M16.13M
EPS (Diluted)2.392.622.691.961.812.972.252.441.141.951.811.731.991.842.462.752.462.111.741.260.800.500.430.36
EPS Growth %-13.92%-2.6%37.24%8.29%-39.06%32%-7.79%114.04%-41.54%7.73%4.62%-13.07%8.15%-25.2%-10.55%11.79%16.59%21.26%38.1%57.5%60%16.28%19.44%-
EPS (Basic)-2.662.742.001.843.072.302.511.181.981.851.752.021.862.472.782.502.151.791.310.850.540.470.36
Diluted Shares Outstanding94.52M97.48M97.33M97.59M101.98M104.62M102.94M104.57M106.98M103.29M102.42M103.86M103.63M102.79M107.54M112.55M115.39M115.37M114.78M113.57M111.66M104.22M92.78M86.08M
Basic Shares Outstanding94.24M95.87M95.54M95.79M99.99M101.19M100.56M101.63M103.38M101.78M100.72M102.35M102.15M101.88M106.93M111.44M113.45M113.1M111.49M109.2M105.69M96.97M85.56M85.01M
Dividend Payout Ratio-49.64%43.76%51.53%54.36%28.74%38.29%30.37%158.47%28.27%26.04%22.61%-215.67%----------

Key Metrics

Growth RegimeMixed
ProfitabilityStable
Balance SheetFortress
Cash FlowStable
Top Statement Risk

AV1 codec adoption threat

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Growth Stalls Amid Mixed Drivers

Revenue growth has been erratic, with Q2 2026 up 7.1% but Q3 2026 down 3.3%, reflecting volatile licensing and product cycles. According to the latest income statement data, the 10-quarter average growth is roughly 2.5%.

The revenue trajectory shows a pattern of alternating quarters of growth and contraction, with no clear sustained acceleration. The Q2 2026 spike to $395.6M appears to be an outlier, possibly driven by catch-up payments or timing effects, while Q3 2026 fell back to $305.0M, near the levels seen in Q4 2025. This volatility suggests that the company's licensing revenue is sensitive to OEM shipment cycles and audit-driven adjustments, making the underlying growth trend appear stagnant. Investors should monitor whether the maintained guidance of $362M-$392M for the next quarter implies a recovery or if the recent miss signals a structural slowdown.

Gross Margin Resilience Masks Operating Pressure

Gross margins have remained remarkably stable, hovering between 86% and 90% over the past ten quarters, as reported in the income statement data. However, operating margins have shown wider swings, from 9.7% to 30.3%, indicating that cost control is the primary variable.

The gross margin stability underscores the IP-centric business model, with minimal cost of goods sold. Yet, the operating margin volatility is striking: Q3 2026 saw operating margin drop to 12.5% from 29.1% in the prior quarter, driven by a sharp increase in SG&A to $160.7M and a revenue decline. This suggests that while the core licensing economics are sound, the company's expense base is not scaling down with revenue, leading to operating leverage that works against it in weaker quarters. The elevated SG&A may reflect investments in sales and marketing for new initiatives like Dolby.io, but the lack of corresponding revenue growth warrants scrutiny.

Operating Leverage Turns Negative in Soft Quarters

Operating income has been highly volatile, with Q3 2026 operating income of $38.3M representing a 67% drop from Q2 2026's $115.1M, as per the income statement data. This indicates that fixed costs are not being adequately covered during revenue dips.

The data reveals that operating income is not scaling proportionally with revenue. In Q2 2026, a 7.1% revenue increase led to a 2.8% increase in operating income, but in Q3 2026, a 22.9% revenue decline caused operating income to plummet by 66.7%. This asymmetry highlights a high fixed-cost structure, particularly in R&D and SG&A, which do not flex downward. The company's operating leverage is positive in up quarters but severely negative in down quarters, making earnings highly sensitive to revenue fluctuations. This pattern suggests that management has limited ability to control costs in the short term, and investors should expect continued earnings volatility.

EPS Volatility Driven by One-Offs and SBC

Earnings per share have swung from $1.01 in Q2 2024 to $0.30 in Q3 2026, with stock-based compensation averaging around $30M per quarter, as reported in the income statement data. This suggests that reported EPS may not fully reflect cash earnings.

The wide EPS range indicates that net income is subject to significant non-operating items and timing effects. For instance, Q4 2025 saw net income of $49.3M despite operating income of only $29.7M, implying a tax benefit or other income boost. Conversely, Q3 2026 net income of $28.6M was lower than operating income of $38.3M, suggesting a higher effective tax rate or other charges. Additionally, stock-based compensation of $31.0M in Q3 2026 represents a substantial portion of operating income, indicating that a significant share of employee compensation is non-cash. Investors should adjust for SBC to assess true cash-generative power, and the recent EPS miss of $0.69 vs. $1.2 estimate may be partly attributable to such items.

SG&A Escalation Pressures Operating Income

SG&A expenses have risen from $146.8M in Q3 2024 to $160.7M in Q3 2026, an increase of 9.5%, while revenue has only grown 5.6% over the same period, according to the income statement data. This suggests a structural cost creep.

The SG&A line has been the primary driver of operating margin compression. In Q3 2026, SG&A as a percentage of revenue reached 52.7%, up from 50.8% in Q3 2024. This increase may reflect investments in sales infrastructure for new initiatives like Dolby.io and OptiView, but the lack of corresponding revenue acceleration raises questions about the efficiency of these expenditures. R&D spending has remained relatively stable as a percentage of revenue, around 19-20%, indicating a consistent commitment to innovation. However, the rising SG&A burden, combined with revenue stagnation, suggests that the company may be spending more to defend its market position or expand into new areas without immediate payoff. Management's expense discipline will be critical to restoring operating margins.

Q2 2026 Spike Masks Underlying Stagnation

The most notable inflection occurred in Q2 2026, where revenue jumped to $395.6M and operating income to $115.1M, the highest in the dataset, as per the income statement data. This appears to be an anomaly rather than a trend.

Q2 2026 stands out as a peak quarter, with revenue and operating income significantly above the surrounding quarters. The gross margin of 88.7% and operating margin of 29.1% were also near the top of the range. However, the subsequent quarter saw a sharp reversal, with revenue falling to $305.0M and operating income to $38.3M, suggesting that the Q2 performance was not sustainable. This pattern may indicate a one-time benefit, such as a large catch-up payment or a surge in licensing from a major OEM cycle. The lasting impact is that it sets a high bar for comparison, making subsequent quarters appear weak. Investors should be cautious about extrapolating from this single quarter and instead focus on the underlying trend of modest growth and margin pressure.

The Bear Case: Margin Compression and Codec Threat

The most compelling bear argument is that the company's high margins are unsustainable due to rising SG&A and the threat of royalty-free codecs like AV1, which could erode pricing power. As reported in the income statement data, operating margins have already shown significant volatility.

Short-sellers might argue that the recent EPS miss and the wide guidance range indicate that the company is losing pricing power. The increase in SG&A without corresponding revenue growth suggests that the company is spending more to defend its market position, possibly due to competitive pressures from free alternatives like AV1 and HDR10+. If streaming platforms continue to adopt royalty-free codecs, Dolby's licensing revenue could face structural decline. Additionally, the company's reliance on the cyclical consumer electronics market, particularly in Asia-Pacific, makes it vulnerable to global demand shocks. The balance sheet is strong, but the income statement shows a business that may be past its peak profitability. Investors should monitor whether the company can maintain its premium brand positioning or if it will be forced to lower royalty rates to retain customers.

DLB — Frequently Asked Questions

Quick answers to the most common questions about buying DLB stock.

What was Dolby Laboratories, Inc.'s (DLB) revenue in 2025?

For fiscal year 2025, Dolby Laboratories, Inc. (DLB) reported total revenue of $1.35B. This represents a 520.4% increase compared to $217.5M in 2003.

Is Dolby Laboratories, Inc. (DLB) profitable?

Dolby Laboratories, Inc. (DLB) is profitable, generating $255.0M in net income for the fiscal year ending 2025 with a net profit margin of 18.9%.

What is Dolby Laboratories, Inc.'s operating profit margin?

Dolby Laboratories, Inc. (DLB) reported an operating income of $265.0M, resulting in an operating profit margin of 19.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Dolby Laboratories, Inc.'s gross profit and gross margin?

Dolby Laboratories, Inc. (DLB) generated $1.19B in gross profit for the year, representing a gross profit margin of 88.1%. This demonstrates the company's core pricing power and production efficiency.